Liver Diseases  >>  Defitelio (defibrotide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Defitelio (defibrotide) / IRCCS San Raffaele Hospital, Jazz
NCT00358501: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Completed
3
134
US, Canada
Defibrotide
Jazz Pharmaceuticals, FDA Office of Orphan Products Development
Severe Hepatic Veno-Occlusive Disease
09/08
03/15
VOD-DF, NCT00272948 / 2004-000592-33: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Completed
2/3
360
Europe, RoW
Defibrotide
European Society for Blood and Marrow Transplantation, Jazz Pharmaceuticals, Deutsche Krebshilfe e.V., Bonn (Germany)
Hepatic Veno-Occlusive Disease
01/09
07/09

Download Options